Sacituzumab tirumotecan demonstrated a 31% objective response rate and 71% disease control rate in advanced urothelial ...

Dubuisson North Zone returns two distinct thick, high-grade intercepts within the same drillhole; renewed follow-up drilling ...

XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...

Wesdome Gold Mines Ltd. (TSX:WDO, OTCQX:WDOFF) ("Wesdome" or the "Company") today provides an update on surface exploration ...

In a critical analysis of India’s economic data, the International Monetary Fund (IMF) has given a ‘C,’ or the second-lowest ...

Cedarville University: A group of third graders dashed across a field, ropes in hand, learning about transportation the ...

Columbia Bond Fund navigated Q3 2025, returning 1.91% amid resilient markets and Fed rate cuts. Read the full report now to ...

Oasis Academy is preparing to welcome new students for the 2026-27 school year, with enrollment officially beginning Dec. 1 ...

And vacancy tightened to 0.7%. Elevated global uncertainty continues to weigh on sentiment, but Japan’s outlook is steadily ...

The twisted mind behind such genre megaliths as the "Conjuring" and "Insidious" franchises is set to breathe new life into ...

“Olomorasib, in combination with pembrolizumab, has demonstrated significant efficacy and a manageable safety profile in patients with KRAS G12C-mutant advanced/metastatic NSCLC, including patients ...

With strong discovery potential and upcoming resource updates, Mumbezhi is poised for substantial growth and progress in 2026 ...